Trial Search Results

Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer

To screen women who are high risk for breast cancer with breast MRI, mammogram and random periareolar fine needle aspiration.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institutes of Health (NIH)

Stanford Investigator(s):


Inclusion Criteria:Subjects must be female, between the ages of 25 and 65, or ten years
younger than the youngest breast cancer diagnosed in the family, or have no mutation
identified but have a greater than 10% risk of developing breast cancer in ten years (based
on the Claus Model).

May have had previous breast or ovarian cancer, but must be at least one year out from
treatment of a Stage 1 or early 2 cancer.

Ages Eligible for Study

25 Years - 65 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Meredith Mills